Product Code: RP-ID-10299178 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10299178
Market Overview:
Global Flow Cytometry Market Size study, by Product Type (Instrument, Fluorophore, Kit and Reagent, Software and Other Product Types), By Technology (Cell-based Flow Cytometry and Bead-based Flow Cytometry), By Application (Oncology, Drug Discovery, Disease Diagnosis, Stem Cell Therapy, Organ Transplantation, Hematology and Other Applications), By End-User (Hospitals and Clinics, Academia and Research Institutes, Pharmaceutical and Biotechnology Companies and Other End Users) and Regional Foreca
Global Flow Cytometry Market is valued approximately at USD 303.51 million in 2018 and is anticipated to grow with a healthy growth rate of more than 8.30% over the forecast period 2019-2026. Flow cytometry is a laser-based, biophysical that analyzes and measures several physical characteristics of particles or cells suspended in a fluid, when passed through a laser beam. Also, the flow cytometry technology is widely used in various fields of diagnostics of diseases such as HIV, Cancer and hematological malignancies. Additionally, Flow Cytometry to witness prominent growth owing to the incorporation of AI Platforms in flow cytometry workflows and advancements in flow cytometry software. As a result, the demand & adoption for Flow Cytometry would increase thereby, making its way for the growth of the market. The growth of the market is primarily driven by the rising prevalence of cancer and HIV along with the increasing private-public initiatives in the field of immune-oncology research. For Instance: In September 2018, France researcher named Pierre Burguiere has conducted a research on the development of next-generation flow cytometry protocols allowing the emergence of new approaches in the field of microbial analysis. Through this research, new approaches would be introduced to illustrate flow cytometry for microbiological analysis for determination of microorganism’s susceptibility to antimicrobial compounds. Also, these new approaches rely on flow cytometry viability assays that can be combined with antibodies and nucleic acid. Similarly, in January 2018, Cancer Genetics has expanded its immune- oncology panel to a new advanced IO panel using flow cytometry-based biomarker panel. These efforts are contributed to strengthen clinical research particularly on new therapeutic strategies and innovative drug treatments to develop new drugs to improve researches thereby, reinforcing the growth of the market. However, significant product costs and limited purchasing power of end-user are expected to impede the growth of the market over the forecast period.
The regional analysis of global Flow Cytometry market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is expected to hold a notable share in the world in terms of revenue owing to the rising prevalence of chronic diseases and rise in the expansion of novel technologies and products. The dominance of the region is witnessed owing to the ongoing researchers and clinical trials. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period. Factors such as rising public-private initiative aimed towards boosting advance research practices and increase investment to promote flow-cytometry based research is expected to create lucrative prospects for the growth pf the region during the forecast period of 2019-2026.
Major market player included in this report are:
Becton, Dickinson and Company
Beckman Coulter Inc.
EMD Millipore (Merck KGaA)
Bio-Rad Laboratories Inc.
Luminex Corporation
Life Technologies
Miltenyi Biotech
Sysmex Partec
Agilent Technologies Inc.
Thermo Fisher Scientific
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Instrument
Fluorophore
Kit and Reagent
Software
Other Product Types
By Technology:
Cell-based Flow Cytometry
Bead-based Flow Cytometry
By Application:
Oncology
Drug Discovery
Disease Diagnosis
Stem Cell Therapy
Organ Transplantation
Hematology
Other Applications
By End-User:
Hospitals and Clinics
Academia and Research Institutes
Pharmaceutical and Biotechnology Companies
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Flow Cytometry Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Beckman Coulter Inc.
EMD Millipore (Merck KGaA)
Bio-Rad Laboratories Inc.
Luminex Corporation
Life Technologies
Miltenyi Biotech
Sysmex Partec
Agilent Technologies Inc.
Thermo Fisher Scientific
Related Reports
Proof of Quality & Reliability
